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Objective: Gastric emptying measurements are mandatory in gastroparesis diagnostics, but 
the association between delayed emptying and symptoms is questionable. It is imperative to 
find biomarkers better correlated to symptom generation. Hence, we examined the associa-
tion between symptom severity and gastrointestinal motility measured by wireless motility 
capsule.
Patients and Methods: In this prospective single-centre study, patients with gastroparesis 
symptoms were simultaneously investigated with gastric emptying scintigraphy and wireless 
motility capsule, measuring regional transit times and contractility parameters. Symptom 
severity was assessed with the Patient Assessment of Upper Gastrointestinal Symptom 
Severity Index (PAGI-SYM), including the Gastroparesis Cardinal Symptom Index (GCSI).
Results: We included 107 patients (70% women). In the whole patient group, nausea 
correlated with the gastric (rs = −0.31, p = 0.007), small bowel (rs = −0.41, p < 0.001) 
and colonic (rs = −0.33, p = 0.012) motility indices. In patients with idiopathic etiology, 
nausea correlated with small bowel motility index (rs = −0.81, p < 0.001) and mean stomach 
pressure (rs = −0.64, p = 0.013). We also found negative correlations between total GCSI 
score and maximum pressure of the small bowel (rs = −0.77, p < 0.001) and colon (rs = 
−0.74, p = 0.002). In diabetes patients, total PAGI-SYM score correlated with colonic 
motility index (rs = −0.34, p = 0.012), and mean pressure of the colon correlated with 
upper abdominal pain (rs = −0.37, p = 0.007). We found no association between symptoms, 
gastric emptying nor any other transit times.
Conclusion: In patients with gastroparesis symptoms, we found that symptom severity was 
associated with intestinal hypomotility. Based on these results, gastroparesis diagnostics 
should also include an evaluation of the small bowel and colon.
Keywords: gastric emptying, gastrointestinal motility, gastroparesis, gastroparesis-like 
syndrome, small bowel, wireless motility capsule, scintigraphy
Introduction
Gastroparesis is defined by delayed gastric emptying in the absence of mechanical 
obstruction.1 Cardinal symptoms are nausea and vomiting, bloating and postpran-
dial fullness, but abdominal pain and fatigue are also common.2 Gastroparesis-like 
syndrome is a diagnostic group where patients have symptoms of gastroparesis, 
similar histopathological alterations, similar response to therapy, but normal gastric 
emptying.3–5 Furthermore, the distinction between gastroparesis, gastroparesis-like 
syndrome and functional dyspepsia is unclear. Most gastroparesis patients fulfill the 
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Rome criteria for functional dyspepsia, while more than 
25% of the patients with functional dyspepsia have 
delayed gastric emptying, blurring the distinction 
further.6–8
Several underlying conditions may lead to gastropar-
esis, including diabetes mellitus, iatrogenic causes such as 
medications or surgery, neurological disorders such as 
Parkinson’s disease and rheumatic disorders.9,10 In 
a subset of patients, no underlying cause is found. 
However, the pathophysiology is gradually becoming 
unraveled, and in a subgroup of the patients, a prior infec-
tion may be the underlying cause.11
Gastric emptying scintigraphy is the current gold stan-
dard for gastric emptying measurements, but the associa-
tion between delayed emptying and symptoms is 
uncertain.1,10,12–15 Furthermore, some studies have shown 
dysmotility of the small bowel or colon in a subgroup of 
patients with gastroparesis, indicating the need for more 
extensive gastrointestinal motility assessment.16–20 
However, the gold standard for measuring small bowel 
and colonic motility, catheter-based manometry, is inva-
sive and unpleasant for the patients and show little relation 
to symptoms. Interpretation also requires specialized qua-
lifications, and the method therefore has limited 
availability.21 In recent years, the wireless motility capsule 
(SmartPill®, Medtronic Inc., Minneapolis, USA) has 
emerged as a potential diagnostic alternative. The wireless 
motility capsule is a non-digestible capsule measuring 
pressure, pH, and temperature throughout the gastrointest-
inal tract. In addition to gastric emptying time, the capsule 
assesses motility in other gastrointestinal regions. 
However, the literature relating wireless motility capsule 
findings and symptoms is still limited.
Consequently, the aim of this study was to explore the 
association between symptom severity, transit times and 
contractility parameters measured by the wireless motility 
capsule in a cohort of patients with gastroparesis 
symptoms.
Patients and Methods
Patients with symptoms compatible with gastroparesis 
referred to Haukeland University Hospital, Bergen, 
Norway, from their local hospital, were prospectively 
included from 2014 to 2018. Symptoms of gastroparesis 
and previous upper endoscopy to exclude mechanical 
obstruction were inclusion criteria in this study.
Medications potentially affecting gastrointestinal moti-
lity were paused before and during the study, including 
proton pump inhibitors (7 days in advance), histamine H2 
receptor antagonists, opioid analgesics, nonsteroidal anti- 
inflammatory drugs, anti-diarrheal drugs, prokinetic 
agents, antiemetic drugs (3 days in advance), laxatives 
(two days), and over-the-counter antacids and alginates 
(24 hours). Ingestion of alcoholic drinks was not allowed 
for the last 48 hours and during examinations. Inability to 
cooperate during medical procedures, pregnancy, breast 
feeding or failure to discontinue medications excluded 
the patient from the study.
Motility Tests
Following an overnight fast from 8 PM, patients under-
went simultaneous assessment by wireless motility capsule 
and gastric emptying scintigraphy starting at 9 AM. To 
allow for simultaneous testing, patients first ingested 
a cereal bar (SmartBar®, Medtronic Inc., Minneapolis, 
USA; containing 260 kcal, 75% carbohydrate, 21% pro-
tein, 3% fat, 3% fiber) together with a boiled egg radi-
olabeled with Tc-99m-nanocolloid (75 kcal, 1.1% 
carbohydrate, 13% protein, 11% fat, 0% fiber). 
Immediately afterwards, the wireless motility capsule 
was swallowed. Together with the meal, patients were 
allowed to drink 120 mL of still water. The patient then 
had to fast for another 6 hours but could drink an addi-
tional 100 mL of water.
Gastric Emptying Scintigraphy
Using a double-headed camera system (Siemens e.cam; 
Siemens Healthineers Inc., Hoffman Estates, USA), ante-
rior and posterior images of the patient in the supine 
position were obtained 30 minutes, 1, 2, 3 and 4 hours 
after meal ingestion. Regions of interest were identified as 
previously described.15 Delayed gastric emptying was 
defined as greater than 10% residual activity after 4 
hours as recommended by Abell et al.22
Wireless Motility Capsule
The wireless motility capsule is a 26.8×11.7 mm capsule 
coated with polyurethane. It contains a radio transmitter, 
an antenna, two 1.5-V batteries and sensors measuring pH 
(range 0.5–9.0), pressure (0–350 mmHg) and temperature 
(25–49°C).23 After ingestion, data were continuously 
transmitted to a wireless recorder worn by the patient 
during the entire examination. After five days, patients 
returned the recorder, whereupon data was transferred to 
a personal computer and analyzed using the MotiliGI® 
software (Medtronic Inc.). Changes in pH were used to 
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identify the gastric and small bowel regions.24,25 In 
patients where these landmarks were hard to define, con-
sensus was obtained between two or more investigators.
Motility and contractility parameters calculated for 
each region included transit time, contractions 
per minute, mean pressure, maximum amplitude of con-
tractions and the motility index.24 The motility index is 
a parameter integrating all contractions >10 mmHg over 
baseline pressure as an area under the pressure–time curve, 
as originally described by Ouyang et al.26 The motility 
index as it appears in MotiliGI is shown in Figure 1.
Questionnaires
To assess patients’ symptoms, we used the Patient 
Assessment of Upper Gastrointestinal Symptom Severity 
Index (PAGI-SYM), a standardized questionnaire vali-
dated for this patient group.27 Patients received the ques-
tionnaire by mail and were instructed to complete it prior 
to arrival.
PAGI-SYM consists of 20 questions regarding upper 
gastrointestinal symptoms during the preceding 2 weeks. 
Each question is graded from 0 to 5 on a Likert scale. 
PAGI-SYM has six subscales: 1) nausea/vomiting, 2) full-
ness/early satiety, 3) bloating, 4) upper abdominal pain, 5) 
lower abdominal pain and 6) heartburn/regurgitation.28 In 
this study, we discarded questions regarding lower abdom-
inal pain or discomfort and heartburn/regurgitation. The 
Gastroparesis Cardinal Symptom Index (GCSI) is calcu-
lated by averaging the scores of subscales 1–3.29 GCSI 
scores are graded into mild (0–2.99), moderate (3.0–3.99) 
and severe (4.0–5.0) symptoms compatible with 
gastroparesis.6
Data Collection and Statistics
Information about patients was de-identified and stored on 
a server as encrypted data. For data analysis, we used IBM 
SPSS Statistics (Ver. 26, IBM Corporation, USA). 
Shapiro–Wilks’ test was used to assess normality. All 
results were summarized as median value with interquar-
tile range (IQR). Mann–Whitney U-test was used to com-
pare differences between groups. Chi square test was used 
to compare differences between distributions. Group com-
parisons were only made between the diabetic and idio-
pathic subgroups, as other etiological groups were too 
small to be included in analysis. Spearman’s Rank Order 
Correlation test was used to evaluate associations between 
continuous variables. To correct for multiple comparisons, 
we performed the Benjamini-Hochberg procedure. The 
significance threshold for each comparison was adjusted 
with a set false discovery rate of 5%.30
Ethical Considerations
The study was approved by The Western Norway Regional 
Medical Ethics Committee (2015/58) and was conducted 
in accordance with the Declaration of Helsinki. All sub-
jects signed informed consent.
Results
The study population consisted of 107 patients (75 
women) who fulfilled the inclusion criteria. Of these, 105 
patients were examined with scintigraphy and motility 
capsule testing. Due to signal loss or other technical errors, 
output from 96 wireless motility capsule recordings was 
included for analysis. Eighty-eight patients completed the 
PAGI-SYM questionnaire. Inclusion flow chart is pre-
sented in Figure 2.
All Patients
Clinical characteristics of all patients are presented in 
Table 1. Diabetes patients were older (p = 0.001), had 
higher BMI (p < 0.001) and used more medications (p < 
0.001) than idiopathic patients. When comparing sub-
groups, idiopathic patients had more nausea, Table 2. 
Thirty-seven patients (35.2%) had delayed 4-hour scinti-
graphy. Of these, 28 had diabetes (24.8%), 7 (6.4%) were 
idiopathic, 1 post-operative (0.9%) and 1 of rheumatic 
(0.9%) origin.
In all patients, we found negative correlations between 
nausea and motility index of the stomach (rs = −0.31, p = 
0.007), small bowel (rs = −0.41, p < 0.001), and colon 
(rs = −0.33, p = 0.012), as shown in Figure 3.
When comparing patients with normal and delayed 
gastric emptying, we found no differences in symptom 
severity (Table 2). Neither did we find correlations 
between symptoms and 4-hour scintigraphy nor any regio-
nal transit time measured by the wireless motility capsule.
Table 3 shows gastrointestinal regional and whole gut 
transit times and comparisons between etiologic sub-
groups. Significantly more patients in the idiopathic 
patient group had normal whole gut transit time. We 
found no other significant differences among diabetic and 
idiopathic patients.
Idiopathic Etiology
In the subgroup with idiopathic etiology, 15 (64%) were 
female and median (IQR) age was 28 years (24–44). Here, 
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Figure 1 WMC recordings showing temperature (blue tracing), pH (green) and pressure recordings (red), time of ingestion (blue vertical line), gastric emptying (grey 
vertical line), ileocecal junction (green vertical line) and capsule expulsion (pink vertical line). Isolated pressure recordings from the two first hours of the small bowel from 
each recording are enlarged below. The MI is expressed as mmHg*seconds/minute and is calculated as the summed area under the amplitude curve for contractions 
>10mmHg, divided by the time window used. Calculation was performed using the MotiliGI® software. (A) WMC results from a patient with impaired small bowel MI. (B) 
WMC results from a patient with normal small bowel MI. 
Abbreviations: WMC, wireless motility capsule; MI, motility index.
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symptoms had lasted for a median of 3 years (2–8), BMI 
was 20.6 kg/m2 (19.0–22.4) and two patients used opioids. 
Symptom scores of the idiopathic patient group are shown 
in Table 2.
In idiopathic patients, we found negative correlations 
between mean pressure of the stomach (rs = −0.64, p = 
0.013), small bowel motility index (rs = −0.81, p < 0.001) 
and nausea, as shown in Figure 4. We also found negative 
correlations between maximum pressure of the small 
bowel and the subscales of early satiety/postprandial full-
ness (rs = −0.75, p = 0.002), early satiety (rs = −0.78, p < 
0.001), postprandial fullness (rs = −0.69, p = 0.006), 
bloating (rs = −0.79, p < 0.001), abdominal distension (rs 
= −0.67, p = 0.007) and the GCSI total score (rs = −0.77, 
p < 0.001), Figure 4. Furthermore, we found a negative 
correlation between maximum pressure of the colon and 
early satiety (rs = −0.77, p < 0.001), postprandial fullness 
(rs = −0.78, p = < 0.001), bloating (rs = −0.67, p = 0.009) 
Figure 2 Study flow chart.
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and the GCSI total score (rs = 74, p = 0.002). There were 
no significant correlations between any symptom score 
and 4-h scintigraphy nor any regional transit time.
Diabetic Etiology
In the subgroup with diabetes, 49 (68.1%) were female 
and median age was 50 years (IQR 37–56). Symptoms had 
lasted for a median of 5 years (2–10), BMI was 25.6 kg/m2 
(22.0–29.4) and 19 patients (26%) used opioids. Symptom 
scores for the diabetes group are shown in Table 2.
In diabetes patients, we found a negative correlation 
between colonic motility index (rs = −0.34, p = 0.012) and 
the PAGI-SYM total score, as shown in Figure 5. We also 
found negative correlations between mean pressure of the 
colon (rs = −0.37, p = 0.007) and upper abdominal pain, 
and between the mean pressure of the colon (rs = −0.36, 
p = 0.008) and the composite score of upper abdominal 
pain. We did not find any correlation between any other 
symptom score and motility capsule contractility para-
meters. Neither did we find any association with delayed 
4-h scintigraphy nor any regional transit time.
Discussion
In this prospective study, we investigated patients with 
gastroparesis symptoms using gastric emptying scintigra-
phy and wireless motility capsule. Our aim was to explore 
the association between gastrointestinal motility and 
symptom severity. In patients with idiopathic etiology, 
we found moderate to strong negative correlations 
between gastric and small bowel motility and nausea. 
We also found strong negative correlations between total 
GCSI score and maximum pressure of the small bowel 
and colon. In diabetes patients, we found moderate nega-
tive correlations between colonic motility, total PAGI- 
SYM score and upper abdominal pain. In the whole 
patient group, we found moderate negative correlations 
between gastric, small bowel and colonic motility and 
nausea. We found no associations between symptom 
scores and gastric emptying, nor with any other transit 
time.
The most notable finding of our study was the strong 
association between upper gastrointestinal symptoms and 
reduced small bowel motility in patients with suspected 
idiopathic gastroparesis. Our findings are reminiscent of 
those made by Barshop et al, when they discovered 
a moderate correlation between duodenal motility and 
gastroparesis symptoms.31 But in contrast to our study, 
they only included patients with delayed gastric emptying. 
Small bowel dysmotility has previously been shown in 
gastroparesis patients of all etiologies, but the relationship 
between small bowel motility and symptoms has been 
conflicting, with few studies involving patients with nor-
mal gastric emptying.18,31,32 The latter is a weakness of the 
research field, given the questionable relationship between 
delayed gastric emptying and patient reported symptoms.
New studies are now emerging, focusing on pathology 
outside of gastric emptying, as exemplified by a recent 
study by Cogliandro et al.20 They used gastric emptying 
breath tests and small bowel manometry to demonstrate 
that 80% of the patients with gastroparesis symptoms had 





Diabetic, n (%) 72 (67.2)
Type 1 diabetes, n (%) 59 (55.1)
Type 2 diabetes, n (%) 13 (12.1)
Idiopathic, n (%) 23 (21.5)
Post-operative, n (%) 4 (3.7)
Rheumatic, n (%) 3 (2.8)
Neurologic, n (%) 3 (2.8)
Miscellaneous*, n (%) 2 (1.9)
Gender (male/female), n 32/75
Age, years 46 (31.3–56)
Symptom duration, years 4 (2.0–9.8)
BMI, kg/m2 24.1 
(20.5–28.7)
Total amount of medications, number 6 (3–10)
Number of opioid users, n (%) 26 (24.2)
Units of alcohol consumed per week 1 (0–1.0)




On disability benefits, n (%) 71 (67.6)
Employed, n (%) 18 (17.1)
Student, n (%) 6 (5.7)
Retired, n (%) 10 (9.5)
Marital status (single/married or cohabitant), n 37/68
Notes: Data are given as median and interquartile range unless otherwise indi-
cated. Frequencies are given as n and valid percent. *One colonic Crohn’s disease, 
one cystic fibrosis. 
Abbreviation: BMI, body mass index.
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enteric dysmotility, while only 24% had delayed gastric 
emptying. They also found that patients with enteric dys-
motility often had more severe disease. However, contrast-
ing our findings, they found no difference in symptoms 
comparing patients with and without enteric dysmotility.
When looking at all patients together, we identified an 
association between reduced colonic motility index and 
nausea. Similar findings were made by Kolar et al.33 
They found that a large proportion of patients with chronic 
nausea and vomiting, had findings consistent with colonic 
transit or rectal evacuation disorders. Hasler et al, on the 
other hand, found no difference in most gastroparesis 
symptoms when comparing patients with high and low 
number of colonic contractions.16 However, they did find 
an association between reduced colonic motility and upper 
abdominal pain, the same as we did in our diabetes group. 
Our findings in idiopathic patients also support an associa-
tion between upper gastrointestinal symptoms and colonic 
hypomotility.
Comparing symptoms in patients with normal and 
delayed gastric emptying, we found no difference with 
neither scintigraphy nor wireless motility capsule. These 
Table 3 Intestinal Transit Times
Transit Times Etiology P-value*
All Patients Diabetes Idiopathic
Gastric emptying time 353 minutes (252–1432) 340 minutes (208–1490) 344 minutes (260–1198) 0.958
Rapid (<105 minutes) 0 0 0 -
Normal 42 32 7 0.399
Delayed (>300 minutes) 54 35 12 0.399
Small bowel transit time 300 minutes (220–401) 280 minutes (213–368) 356 minutes (287–469) 0.018
Rapid (<135 minutes) 4 3 1 0.869
Normal 87 50 17 0.757
Delayed (>480 minutes) 2 2 0 0.451
Colonic transit time 2618 minutes (1124–4487) 2618 minutes (1163–4300) 2856 minutes (1046–4277) 0.903
Rapid (<300 minutes) 6 5 0 0.221
Normal 49 33 10 0.764
Delayed (>3030 minutes) 38 26 8 0.771
Whole gut transit time 4166 minutes (2079–6269) 3714 minutes (2079–6073) 3576 minutes (1613–5342) 0.770
Rapid (<645 minutes) 0 0 0 –
Normal 47 34 10 0.050
Delayed (>4125 minutes) 49 33 9 0.932
Notes: Intestinal transit times reported as median and interquartile range. Number of patients divided into groups of rapid, normal and delayed transit times in each 
intestinal segment according to cut-offs as proposed by Wang et al.25 *Comparison of idiopathic and diabetic patients assessed by Mann–Whitney U-test and Chi square 
test.
Figure 3 Correlations between symptom severity and gastrointestinal motility in the whole patient group. Spearman’s rank-order correlation and linear regression analyses 
were used to examine associations among the variables. (A) Correlation between MI of the stomach and nausea as measured with PAGI-SYM, (B) Correlation between MI 
of the small bowel and nausea as measured with PAGI-SYM. (C) Correlation between MI of the colon and nausea as measured with PAGI-SYM. 
Abbreviations: MI, motility index; PAGI-SYM, Patient Assessment of Gastrointestinal Symptom Severity Index.
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results are in accordance with previous studies.16,34 The 
patients in our normal gastric emptying group likely fulfill 
criteria for both functional dyspepsia and gastroparesis- 
like syndrome. In a recent study, functional dyspepsia 
and gastroparesis was shown to be interchangeable 
syndromes.35 Approximately 40% of the 944 patients in 
the study were reclassified as functional dyspepsia or 
gastroparesis on a 48-week follow-up and this was not 
associated with changes in symptom severity. Both groups 
also showed similar histopathology on full-thickness biop-
sies. Further, gastroparesis-like and gastroparesis also dis-
play similar symptom severity, histopathological changes, 
and myoelectrical activity3–5,36 In this study, we also 
found a strong negative correlation between nausea and 
mean pressure of the stomach in idiopathic patients, con-
trasting other comparable wireless motility capsule 
studies.16,31 A reasonable interpretation may be that 
patients with gastroparesis, the so-called gastroparesis- 
like syndrome and functional dyspepsia are all part of 
a spectrum, where patients with delayed gastric emptying 
have more serious neuromuscular or mesenchymal 
dysfunction.35 Both our normal and delayed gastric emp-
tying group therefore likely have such a gastric neuromus-
cular dysfunction, with or without other intestinal motor 
dysfunction.
Whether the extragastric motor dysfunctions found in 
this study represent pathology of separate gastrointestinal 
disorders or are part of the same spectrum cannot be 
conclusively answered by this study. However, small 
bowel dysmotility is also seen in both patients with gastro-
paresis, functional dyspepsia and irritable bowel 
syndrome.37,38 As discussed previously, impaired colon 
motility are also found in constipated patients. In one 
study using Rome IV criteria, 64% of the patients with 
functional dyspepsia or irritable bowel syndrome was 
shown to fulfill criteria for both disorders.39 It is therefore 
likely that part of our patient group also fulfills criteria for 
irritable bowel syndrome. Further studies systematically 
using Rome IV criteria, pan-enteric motility measures 
and supplemental pathological markers such as full- 
Figure 4 Correlations between symptom severity and small bowel motility in patients with idiopathic etiology. Spearman’s rank-order correlation and linear regression 
analyses were used to examine associations among the variables. (A) Correlation between MI of the small bowel and nausea as measured with PAGI-SYM. (B) Correlation 
between maximum pressure of the small bowel and early satiety/postprandial fullness. (C) Correlation between maximum pressure of the small bowel and bloating. (D) 
Correlation between maximum pressure of the small bowel and GCSI total score. 
Abbreviations: MI, motility index; PAGI-SYM, Patient Assessment of Gastrointestinal Symptom Severity Index; GCSI, Gastroparesis Cardinal Symptom Index.
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thickness biopsies are needed to resolve whether segmen-
tal dysmotility can be attributed to separate disorders in 
patients with similar clinical features.
Interpreting the results, we find it likely that intestinal 
hypomotility plays a more prominent role in the generation 
of gastroparesis symptoms than previously believed. As 
symptoms alone cannot be used to differentiate between 
dysmotility in different gastrointestinal regions, patients 
may benefit from a more comprehensive assessment of 
intestinal motility regardless of gastric emptying rates.40 
Thus, performing gastric emptying scintigraphy alone may 
miss pathology in a significant number of patients. Here, 
the wireless motility capsule might prove to be a good 
alternative, measuring gastric emptying, intestinal transit 
times and other motility parameters in one test. In contrast 
to antroduodenal manometry, the method is very well 
tolerated by patients. Furthermore, the procedure can be 
performed in the outpatient clinic and is easy to interpret, 
with excellent inter-rater reliability.41
Our study had some limitations. The composition of the 
meal served before motility testing deviated somewhat from 
the standard protocol. While the SmartBar® is almost identical 
in caloric and macronutritional content to the standard egg- 
white meal recommended for gastric emptying scintigraphy, 
the addition of a boiled egg elevated the total caloric content 
by 90 kcal as well as containing additional fat and protein. On 
the other hand, simultaneous investigation with scintigraphy 
and wireless motility capsule was a major strength of the 
study, minimizing intra-individual day-to-day variations in 
gastric emptying. To avoid spurious associations, we chose 
to correct for multiple comparisons with the Benjamini– 
Hochberg procedure, a method reducing the risk of type 
I errors, without being so conservative that it facilitates type 
II errors. Another strength of the study was its prospective, 
single-center inclusion, allowing for isolation of the factors we 
wished to test for, as opposed to most studies performed with 
the wireless motility capsule, having a retrospective design.
Conclusions
In this study, we found substantial associations between 
gastroparesis symptoms and intestinal hypomotility mea-
sured by the wireless motility capsule. Associations were 
particularly strong in the idiopathic subgroup. In contrast, 
we found no association between gastric emptying and 
symptoms. Based on our results, pan-enteric investigation 
of motility is recommended in both diabetes and idio-
pathic patients with symptoms suggestive of 
gastroparesis.
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